ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

248 hedge funds and large institutions have $4.11B invested in Alnylam Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 62 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
248
Holders Change
-6
Holders Change %
-2.36%
% of All Funds
6.63%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
33
Increased
109
Reduced
62
Closed
37
Calls
$68.7M
Puts
$33.7M
Net Calls
+$35.1M
Net Calls Change
+$29.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$222M
2
Dodge & Cox
Dodge & Cox
California
$140M
3
DM
Deerfield Management
New York
$18.6M
4
JHIU
Janus Henderson Investors US
Colorado
$19.9M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
$15.4M

Top Sellers

1
Capital World Investors
Capital World Investors
California
$31.8M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
$3.91M
3
VAM
Visium Asset Management
New York
$0
4
Citadel Advisors
Citadel Advisors
Florida
$0
5
Franklin Resources
Franklin Resources
California
$32.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
SO
276
STRS Ohio
Ohio
– -$106K -1,699 Closed
PCM
277
Prelude Capital Management
New York
– -$59K -947 Closed
SWA
278
Sutton Wealth Advisors
Florida
– -$10.7K -170 Closed
WTB
279
Washington Trust Bank
Washington
– -$6K -100 Closed
TRCT
280
Tower Research Capital (TRC)
New York
– -$3K -40 Closed
S
281
SignatureFD
Georgia
– -$2K -37 Closed
TFO
282
Tarbox Family Office
California
– -$1K -10 Closed
8 9 10 11
12